Opportunities Emerge After Bio Stocks Plunge... Selective Approach Recommended for Oversold Stocks

Although overall investor sentiment in the pharmaceutical and bio sectors has weakened due to the sharp decline of large-cap KOSDAQ bio stocks, the securities industry views this as a phase following excessive correction. While short-term negative factors have increased volatility, many analysts believe the drop was excessive when considering core business execution and new partnership achievements. There is also speculation that the current concentration of funds in semiconductors, robotics, and automobiles may become more diversified again.

Market participants are closely monitoring global interest rate trends and the recovery of overseas bio indices as key leading indicators. Experts advise that a selective approach is effective, especially for companies with upcoming technology transfer or clinical events following annual global pharmaceutical and bio conferences. There is growing discussion about mid- to long-term opportunities for stocks that have recently plummeted or those that experienced significant volatility shortly after listing.

[Industry leader HiStockLoan direct link: https://www.hisl.co.kr/5113]

Meanwhile, interest in stock-backed loans continues to rise. Investors who do not want to miss rare investment opportunities are increasingly turning to stock-backed loans to access more capital for stock purchases.

One of the advantages of stock-backed loans is that even if you face a forced sale crisis due to a sharp drop in stock prices while using margin or credit, you can easily switch to a stock-backed loan without providing additional collateral or selling your stocks, and then wait for a rebound.

◆ HiStockLoan offers the industry's lowest annual interest rate in the 4% range, enabling not only additional investment funds but also refinancing of margin and credit accounts!

HiStockLoan has launched a securities-linked credit product with the industry's lowest annual interest rate in the 4% range, allowing anyone to experience stock-backed loans with ease. This product can be used for both stock purchases and refinancing margin/credit accounts at securities firms, and can be leveraged up to four times your own capital, regardless of credit rating.

In addition, for investors who previously had difficulty using stock-backed loans due to DSR limits, products are now available that can be used regardless of DSR. Investors using alternative trading systems (NXT) can also take advantage of these products.

Investors who want to learn more about HiStockLoan's diverse customized products can contact the customer service center (☎1566-5113) for convenient 24-hour consultations with professional advisors, regardless of loan approval.

○ Launched the industry's lowest annual interest rate product in the 4% range

○ Products available regardless of DSR

○ No. 1 market share for 22 consecutive years, winner of the Korea First Brand Award for 17 consecutive years

○ Real-time repayment of securities firm margin/credit accounts

○ Alternative trading system (NXT) transactions available

○ Reliable consultation quality assurance system

* HiStockLoan Consultation Center: 1566-5113

Direct link: https://www.hisl.co.kr/5113

Hulim A-Tech, TPC Global, TXR Robotics, Haesung Aerobotics, Konic Automation

※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.

This content was produced with the assistance of AI translation services.